QV Bioelectronics Raises £735k

Funds to be used for development of implanted electric field therapy device for brain cancer treatment.

EchoNous Secures $60 Million in Funding from Kennedy Lewis Investment Management

Proceeds from the financing will help fuel the commercial launch of Kosmos, EchoNous’ flagship device.

Electroducer Reports Major Medical Advance in RX of Heart Valve Disease. Company Raises €3 Mil to Market Its Device in Europe and the USA Commencing in 2022 

The Electroducer Sleeve is a device with no equivalent anywhere in the world. It is based on a medical technique called Direct Wire Pacing (DWP®), which was invented by the company’s founder, Dr. Benjamin Faurie, and used for the first time ever in 2011.

Bioventus Invests in Vaporox

Ultrasound technology to heal diabetic foot ulcers.

Otolith Labs Announces Closing of $3.3 Million in Seed Financing; Receives “Breakthrough Device” Designation from FDA for Its Prescription Treatment for Vertigo

Investors include Mark Cuban; founders of three companies acquired by large strategics; and four leading ENTs.

Bioretec Completes 7.2 M€ Equity Funding Round

The company focuses to the registration and commercialization of RemeOs™ trauma screws.

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

To date, NuvoAir has partnered with providers across the U.S., U.K. and Europe, including Harvard Boston Children's Hospital, New Hampshire's Dartmouth-Hitchcock Medical Center, Royal Brompton Hospital, King's College Hospital in London, as well as pharmaceutical giants Roche, Regeneron and Novartis.

Trudell Medical Group Makes a Strategic Investment in Xenocor

In addition, George Baran, Chair of the Trudell Medical Group will join the Xenocor board.